Shiv Pillai

Active 1987–2025

98
Papers
20,174
Citations
63
h-index
97
i10-index

Citations

Citations per year for Shiv Pillai1988: 1 citations1990: 9 citations1991: 18 citations1992: 13 citations1993: 46 citations1994: 33 citations1995: 56 citations1996: 41 citations1997: 47 citations1998: 57 citations1999: 52 citations2000: 67 citations2001: 59 citations2002: 106 citations2003: 100 citations2004: 99 citations2005: 96 citations2006: 108 citations2007: 85 citations2008: 120 citations2009: 95 citations2010: 103 citations2011: 98 citations2012: 112 citations2013: 100 citations2014: 115 citations2015: 158 citations2016: 158 citations2017: 154 citations2018: 140 citations2019: 484 citations2020: 661 citations2021: 752 citations2022: 553 citations2023: 393 citations2024: 538 citations2025: 288 citations2026: 4 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,063 citing papers, 30.1% of this breakdownChina: 597 citing papers, 8.7% of this breakdownUnited Kingdom: 458 citing papers, 6.7% of this breakdownGermany: 365 citing papers, 5.3% of this breakdownJapan: 360 citing papers, 5.2% of this breakdownItaly: 320 citing papers, 4.7% of this breakdownFrance: 263 citing papers, 3.8% of this breakdownCanada: 212 citing papers, 3.1% of this breakdownNetherlands: 179 citing papers, 2.6% of this breakdownAustralia: 172 citing papers, 2.5% of this breakdownSwitzerland: 158 citing papers, 2.3% of this breakdownSpain: 152 citing papers, 2.2% of this breakdown
0%30.1%Other 22.8%

Fields

  • Medicine44.8%
  • Immunology and Microbiology32.8%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Neuroscience1.8%
  • Engineering1.2%
  • Nursing0.9%
  • Other3%

Topics

  • Immune Cell Function and Interaction6.1%
  • T-cell and B-cell Immunology6%
  • Galectins and Cancer Biology4.2%
  • Immunotherapy and Immune Responses3.5%
  • IgG4-Related and Inflammatory Diseases3.2%
  • COVID-19 Clinical Research Studies2.9%
  • Other74.1%

Coauthors

All papers

Open in search
  1. B Lymphocytes and Cancer: A Love–Hate Relationship

    Authors: , , - Trends in cancer 2016 cited by 428

  2. IgG4-related disease

    Authors: , , , - The Lancet 2014 cited by 1,200

  3. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ngoc L. Ly, Ashlin R. Michell, Yelizaveta Rassadkina, Kyra Seiger, Libera Sessa, Sally Shin, Nishant K. Singh, Weiwei Sun, Xiaoming Sun, Hannah Ticheli, Michael T. Waring, Alex Zhu, Galit Alter, Jonathan Z. Li, Daniel Lingwood, Aaron G. Schmidt, Mathias Lichterfeld, Bruce D. Walker, Xu G. Yu, Robert F. Padera, Shiv Pillai - Cell 2020 cited by 784

  4. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 187

  5. Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease

    Authors: , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 416

  6. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Galit Alter, David R. Walt, Alessio Fasano - Journal of Clinical Investigation 2021 cited by 257

  7. Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2024 cited by 75

  8. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2019 cited by 152

  9. Galectins: A family of animal β-galactoside-binding lectins

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 1994 cited by 1,207

  10. Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial

    Authors: , , , , , , , , , , , , , , , - The Lancet Rheumatology 2023 cited by 66

  11. The follicular versus marginal zone B lymphocyte cell fate decision

    Authors: , - Nature reviews. Immunology 2009 cited by 547

  12. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease

    Authors: , , , , , , , , - Journal of Allergy and Clinical Immunology 2014 cited by 386

  13. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 496

  14. Siglecs and Immune Regulation

    Authors: , , , - Annual Review of Immunology 2012 cited by 357

  15. Extrafollicular IgD−CD27−CXCR5−CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2023 cited by 48

  16. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease

    Authors: , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2018 cited by 177

  17. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 96

  18. Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease

    Authors: , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 69

  19. IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients

    Authors: , , , , , , - Arthritis & Rheumatology 2015 cited by 657

  20. Disease Severity Linked to Increase in Autoantibody Diversity in IgG4‐Related Disease

    Authors: , , , , , , - Arthritis & Rheumatology 2019 cited by 64

  21. Peripheral B cell subsets

    Authors: , - Current Opinion in Immunology 2008 cited by 530

  22. Is it bad, is it good, or is IgG4 just misunderstood?

    Authors: - Science Immunology 2023 cited by 42

  23. A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4‐Related Disease and Decreases Following Glucocorticoid Treatment

    Authors: , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2018 cited by 116

  24. Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 180